Patents by Inventor Zui Pan

Zui Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for modulating store-operated calcium entry
    Patent number: 8071533
    Abstract: Compositions and methods for modulating activity of store-operated calcium entry in cells or tissues are provided. The compositions comprise the P311 protein, fused to a cell-penetrating peptide and formulated for delivery to tissues and cells. This protein has been shown to increase the levels of store-operated calcium entry (SOCE) in gingival cells, skeletal muscle cells, and prostate epithelial cells. Also provided are methods for preventing and treating diseases that involve administration of the P311 fusion protein, as well as methods for increasing levels of SOCE in cells.
    Type: Grant
    Filed: March 20, 2007
    Date of Patent: December 6, 2011
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventors: Jianjie Ma, Noah Weisleder, Zui Pan
  • Method for identifying diabetic patients at increased risk for pathological complications
    Patent number: 7972798
    Abstract: The present invention provides methods for detecting and measuring, in a sample from a subject, the plasma levels of endothelial cell antibodies to diagnose an increased risk of pathological complications, such as visual impairment, associated with diabetes.
    Type: Grant
    Filed: December 4, 2008
    Date of Patent: July 5, 2011
    Assignee: The United States of America as represented by the Department of Veterans Affairs
    Inventors: Mark B. Zimering, Zui Pan, Janet Alder, Smita Thakker-Varia
  • Compositions and Methods for Modulating Store-Operated Calcium Entry
    Publication number: 20100061942
    Abstract: Compositions and methods for modulating activity of store-operated calcium entry in cells or tissues are provided. The compositions comprise the P311 protein, fused to a cell-penetrating peptide and formulated for delivery to tissues and cells. This protein has been shown to increase the levels of store-operated calcium entry (SOCE) in gingival cells, skeletal muscle cells, and prostate epithelial cells. Also provided are methods for preventing and treating diseases that involve administration of the P311 fusion protein, as well as methods for increasing levels of SOCE in cells.
    Type: Application
    Filed: March 20, 2007
    Publication date: March 11, 2010
    Inventors: Jiangie Ma, Noah Weisleder, Zui Pan
  • Novel method for identifying diabetic patients at increased risk for pathological complications
    Publication number: 20090208511
    Abstract: The present invention provides methods for detecting and measuring, in a sample from a subject, the plasma levels of endothelial cell antibodies to diagnose an increased risk of pathological complications, such as visual impairment, associated with diabetes.
    Type: Application
    Filed: December 4, 2008
    Publication date: August 20, 2009
    Inventors: Mark B. Zimering, Zui Pan, Janet Alder, Smita Thakker-Varia